Literature DB >> 23839157

Rotavirus specific plasma secretory immunoglobulin in children with acute gastroenteritis and children vaccinated with an attenuated human rotavirus vaccine.

Daniel Herrera1, Camilo Vásquez, Blaise Corthésy, Manuel A Franco, Juana Angel.   

Abstract

Rotavirus (RV)-specific secretory immunoglobulin (RV-SIg) has been previously detected in serum of naturally RV infected children and shown to reflect the intestinal Ig immune response. Total plasma SIgA and plasma RV-SIg were evaluated by ELISA in children with gastroenteritis due or not due to RV infection and in 50 children vaccinated with the attenuated RIX4414 human RV vaccine and 62 placebo recipients. RV-SIg was only detected in children with evidence of previous RV infection or with acute RV gastroenteritis. Vaccinees had higher RV-SIg titers than placebo recipients and RV-SIg titers increased after the second vaccine dose. RV-SIg measured after the second dose correlated with protection when vaccinees and placebo recipients were analyzed jointly. RV-SIg may serve as a valuable correlate of protection for RV vaccines.

Entities:  

Keywords:  correlate of protection; rotavirus; secretory immunoglobulin; vaccine

Mesh:

Substances:

Year:  2013        PMID: 23839157      PMCID: PMC3981851          DOI: 10.4161/hv.25610

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  46 in total

1.  Correlation of tissue distribution, developmental phenotype, and intestinal homing receptor expression of antigen-specific B cells during the murine anti-rotavirus immune response.

Authors:  Kenneth R Youngman; Manuel A Franco; Nelly A Kuklin; Lusijah S Rott; Eugene C Butcher; Harry B Greenberg
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

2.  Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.

Authors:  Armelle Phalipon; Ana Cardona; Jean Pierre Kraehenbuhl; Léna Edelman; Philippe J Sansonetti; Blaise Corthésy
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

3.  Metabolic properties of human IgA subclasses.

Authors:  A Morell; F Skvaril; G Noseda; S Barandun
Journal:  Clin Exp Immunol       Date:  1973-04       Impact factor: 4.330

4.  Serum antibody as a marker of protection against natural rotavirus infection and disease.

Authors:  F R Velázquez; D O Matson; M L Guerrero; J Shults; J J Calva; A L Morrow; R I Glass; L K Pickering; G M Ruiz-Palacios
Journal:  J Infect Dis       Date:  2000-10-23       Impact factor: 5.226

5.  Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn.

Authors:  S S Ogra; D Weintraub; P L Ogra
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

6.  Maturation and trafficking markers on rotavirus-specific B cells during acute infection and convalescence in children.

Authors:  María C Jaimes; Olga L Rojas; Eric J Kunkel; Nicole H Lazarus; Dulce Soler; Eugene C Butcher; Dorsey Bass; Juana Angel; Manuel A Franco; Harry B Greenberg
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.

Authors:  Pamela A Kozlowski; Selvi B Williams; Rebecca M Lynch; Timothy P Flanigan; Rosalyn R Patterson; Susan Cu-Uvin; Marian R Neutra
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Mucosal IgG and IgA responses to human papillomavirus type 16 capsid proteins in HPV16-infected women without visible pathology.

Authors:  L Rocha-Zavaleta; A L Pereira-Suarez; G Yescas; R M Cruz-Mimiaga; A Garcia-Carranca; F Cruz-Talonia
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

9.  Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.

Authors:  I C Moura; M N Centelles; M Arcos-Fajardo; D M Malheiros; J F Collawn; M D Cooper; R C Monteiro
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

10.  The immunological development of the human fetus.

Authors:  R van Furth; H R Schuit; W Hijmans
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings.

Authors:  E Clarke; U Desselberger
Journal:  Mucosal Immunol       Date:  2014-12-03       Impact factor: 7.313

2.  Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Authors:  Karla Soares-Weiser; Hanna Bergman; Nicholas Henschke; Femi Pitan; Nigel Cunliffe
Journal:  Cochrane Database Syst Rev       Date:  2019-10-28

3.  Vaccines for preventing rotavirus diarrhoea: vaccines in use.

Authors:  Karla Soares-Weiser; Hanna Bergman; Nicholas Henschke; Femi Pitan; Nigel Cunliffe
Journal:  Cochrane Database Syst Rev       Date:  2019-03-25

4.  Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.

Authors:  Fabián Salas-Cuestas; Wilson Bautista-Molano; Juan M Bello-Gualtero; Ivonne Arias; Diana Marcela Castillo; Lorena Chila-Moreno; Rafael Valle-Oñate; Daniel Herrera; Consuelo Romero-Sánchez
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

Review 5.  Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges.

Authors:  Juana Angel; A Duncan Steele; Manuel A Franco
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.